Regencell Bioscience (RGC) has had the highest return since January 1, 2025 by a US stock with a market cap of $2,012+, returning 12,325.1%.
| ASSET | % RETURN |
|---|---|
Regencell Bioscience (RGC) | 12,325.15% |
QMMM Holdings Limited Ordinary Shares (QMMM) | 9,155.81% |
Abivax SA American Depositary Shares (ABVX) | 1,634.05% |
Diginex Limited Ordinary Shares (DGNX) | 1,404.23% |
FiEE (FIEE) | 1,184.4% |
Oncology Institute (TOI) | 1,135.29% |
Zepp Health (ZEPP) | 994.62% |
Abits (ABTS) | 805.96% |
Palvella Therapeutics (PVLA) | 749.1% |
DeFi Development (DFDV) | 726.27% |
Cidara Therapeutics (CDTX) | 713.91% |
Terns Pharmaceuticals (TERN) | 697.87% |
Celcuity LLC (CELC) | 696.14% |
Relmada Therapeutics (RLMD) | 682.58% |
Newegg Commerce (NEGG) | 675% |
Nanobiotix (NBTX) | 629.9% |
NovaBay Pharmaceuticals (NBY) | 617.95% |
Lizhi (SOGP) | 582.23% |
Galecto (GLTO) | 569.46% |
AXT (AXTI) | 567.12% |
Avino Silver & Gold Mines (ASM) | 552.75% |
Americas Silver (USAS) | 507.37% |
Hycroft Mining (HYMC) | 492.92% |
Sandisk (SNDK) | 488.08% |
TMC the metals (TMC) | 482.46% |
